Next Biomedical Co.,Ltd. (KOSDAQ:389650)

Market Cap	607.08B
Revenue (ttm)	12.16B
Net Income (ttm)	2.57B
Shares Out	8.13M
EPS (ttm)	-273.00
PE Ratio	235.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	63,935
Average Volume	133,433
Open	73,500
Previous Close	73,700
Day's Range	72,100 - 75,500
52-Week Range	27,250 - 86,500
Beta	n/a
RSI	63.92
Earnings Date	n/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 389650